FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to polypeptide options of porcine trypsin, nucleic acid molecules encoding these options, and host cells containing such nucleic acid molecules. It also relates to the use of these options in methods for the production of insulin.
EFFECT: invention allows for obtainment of an effective option of trypsin and obtainment of insulin with a high degree of efficiency.
16 cl, 4 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NGF ANTAGONISTS FOR MEDICAL USE | 2020 |
|
RU2829812C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY AND USE THEREOF | 2020 |
|
RU2819228C2 |
| FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN | 2018 |
|
RU2813996C2 |
| FUSION PROTEIN COMPRISING IL-12 AND ANTI-FAP ANTIBODY, AND USE THEREOF | 2021 |
|
RU2831612C1 |
| VERSION FC AND ITS PRODUCTION | 2021 |
|
RU2828852C1 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
| EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
| CD47-ANTIGEN-BINDING UNIT AND ITS USE | 2018 |
|
RU2780859C2 |
| POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS | 2017 |
|
RU2773052C2 |
